- $27.73m
- $26.19m
- $0.16m
2018 September 30th | 2019 September 30th | 2020 September 30th | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 20-F | 20-F |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.34 | 0.37 | 0.946 | 0.219 | 0.164 |
Cost of Revenue | |||||
Gross Profit | 0.332 | 0.37 | — | — | -0.297 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 8.88 | 0.9 | 0.874 | 3.09 | 20.4 |
Operating Profit | -8.54 | -0.53 | 0.073 | -2.87 | -20.3 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -8.6 | -0.53 | 0.073 | -2.74 | -22.5 |
Provision for Income Taxes | |||||
Net Income After Taxes | -8.6 | -0.53 | 0.073 | -2.74 | -22.5 |
Net Income Before Extraordinary Items | |||||
Net Income | -8.6 | -0.53 | 0.073 | -2.74 | -22.5 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -8.6 | 0.3 | 0.073 | -2.74 | -22.5 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.638 | 0.019 | 0.004 | -0.145 | -0.627 |